XML 48 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities
The following tables present the Company’s financial assets and liabilities measured on a recurring basis using the fair value hierarchy at March 31, 2017 and 2016 (in thousands):
 
Fair Value Measurements at
 
March 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
ASSETS:
 
 
 
 
 
 
 
Cash and cash equivalents
$
304,880

 
$

 
$

 
$
304,880

U.S. government and municipal obligations
40,628

 
80,273

 

 
120,901

Commercial paper

 
29,469

 

 
29,469

Corporate bonds
7,956

 

 

 
7,956

Certificate of deposits

 
1,499

 

 
1,499

Derivative financial instruments

 
110

 

 
110

 
$
353,464


$
111,351


$


$
464,815

LIABILITIES:
 
 
 
 
 
 
 
Contingent purchase consideration
$

 
$

 
$
(5,449
)
 
$
(5,449
)
Derivative financial instruments

 
(213
)
 

 
(213
)
 
$

 
$
(213
)
 
$
(5,449
)
 
$
(5,662
)
 
 
Fair Value Measurements at
 
March 31, 2016
 
Level 1
 
Level 2
 
Level 3
 
Total
ASSETS:
 
 
 
 
 
 
 
Cash and cash equivalents
$
210,711

 
$

 
$

 
$
210,711

U.S. government and municipal obligations
41,116

 
82,212

 

 
123,328

Commercial paper

 
16,172

 

 
16,172

Corporate bonds
1,864

 

 

 
1,864

Derivative financial instruments

 
191

 

 
191

Contingently returnable consideration

 

 
16,131

 
16,131

 
$
253,691

 
$
98,575

 
$
16,131

 
$
368,397

LIABILITIES:
 
 
 
 
 
 
 
Contingent consideration
$

 
$

 
$
(7,293
)
 
$
(7,293
)
Derivative financial instruments

 
(158
)
 

 
(158
)
 
$

 
$
(158
)
 
$
(7,293
)
 
$
(7,451
)
Schedule of Reconciliation of Changes in Fair Value of Level Three Financial Liabilities
The following table sets forth a reconciliation of changes in the fair value of the Company’s Level 3 financial liabilities for the year ended March 31, 2016 (in thousands):
 
Contingent
Purchase
Consideration
 
Contingently Returnable Consideration
Balance at March 31, 2015
$
(4,484
)
 
$

(Increase) / decrease in fair value and accretion expense (included within research and development expense)
(152
)
 

Contingently returnable consideration

 
19,125

Increase in fair value
(21
)
 
3,676

Gross presentation of contingently returnable consideration to contingent purchase consideration
(2,636
)
 
2,636

Payments received

 
(9,306
)
Balance at March 31, 2016
$
(7,293
)
 
$
16,131

The following table sets forth a reconciliation of changes in the fair value of the Company’s Level 3 financial liabilities for the year ended March 31, 2017 (in thousands):
 
Contingent
Purchase
Consideration
 
Contingently Returnable Consideration
Balance at March 31, 2016
$
(7,293
)
 
$
16,131

Additions to Level 3
(660
)
 

Increase in fair value and accretion expense (included within research and development expense)
(153
)
 

Decrease in fair value

 
(610
)
Gross presentation of contingently returnable consideration to contingent purchase consideration
(3,910
)
 
3,910

Payments received

 
(19,431
)
Payments made
6,567

 

Balance at March 31, 2017
$
(5,449
)
 
$